EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells

David A. Puleo, Winston W. Huh

Journal of Applied Biomaterials · 1995-06 · 6 (2) · 109-116

DOI: 10.1002/jab.770060205 ↗
AbstractBibliografische Angaben

Abstract

Abstract The effects of metal ions released from orthopedic implants on nearby bone cells remain largely unknown. The purpose of this study was to examine the acute toxicity of metal ions on osteogenic cells derived from bone marrow. Bone marrow stromalcells were cultured with metal ions found in commonly used orthopedic implants, that is, Ti‐6Al‐4V, Co‐Cr‐Mo, and 316L stainless steel. Solutions of individual ions and combinations representing the alloy composition were prepared from atomic absorption standards and added to the cultures to give concentrations ranging from 50 ppb to 5o ppm. After a 48‐h period of exposure to ions, the bone marrow cultures were examined for effects of cytotoxicity by measuring total cell number, total cell protein, and mitochondrial activity. Cr 6+ was grossly cytotoxic; Co 2+ , Mo 6+ , Fe 3+ , and Ni 2+ were moderately cytotoxic; and Ti 4+ , Al 3+ , V 5+ , and Mn 2+ were minimally toxic, as determined by the assays used. Ion solutions representing Co‐Cr‐Mo and 316L stainless steel were moderately toxic; solutions representing Ti‐6Al‐4V were toxic at only the highest concentrations used. The observed cytotoxicity was time‐dependent, with irreversible toxic effects being initiated following as short as a 3‐ to 6‐hour exposure. These results show that metal ions associated with Co‐Cr‐Mo and 316L stainless steel are toxic to osteogenic cells at concentrations approximating those measured in the fibrous membrane encapsulating orthopedic implants. © 1995 John Wiley & Sons, Inc.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →